These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31669484)

  • 1. Analyzing chemotherapy-induced peripheral neuropathy in vivo using non-mammalian animal models.
    Cirrincione AM; Rieger S
    Exp Neurol; 2020 Jan; 323():113090. PubMed ID: 31669484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drosophila strain specific response to cisplatin neurotoxicity.
    Groen CM; Podratz JL; Treb K; Windebank AJ
    Fly (Austin); 2018; 12(3-4):174-182. PubMed ID: 30668272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms.
    Argyriou AA; Bruna J; Park SB; Cavaletti G
    Expert Rev Neurother; 2020 Oct; 20(10):1005-1016. PubMed ID: 32667212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chemotherapy-Induced Peripheral Neuropathy Model in Drosophila melanogaster.
    Bhattacharya MRC
    Methods Mol Biol; 2020; 2143():301-310. PubMed ID: 32524489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced peripheral neurotoxicity.
    Cavaletti G; Marmiroli P
    Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of iPSC-derived human neurons for high-throughput drug-induced peripheral neuropathy screening.
    Rana P; Luerman G; Hess D; Rubitski E; Adkins K; Somps C
    Toxicol In Vitro; 2017 Dec; 45(Pt 1):111-118. PubMed ID: 28843493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.
    Bruna J; Alberti P; Calls-Cobos A; Caillaud M; Damaj MI; Navarro X
    Exp Neurol; 2020 Mar; 325():113154. PubMed ID: 31837318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced peripheral neuropathy: A current review.
    Staff NP; Grisold A; Grisold W; Windebank AJ
    Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy.
    Chine VB; Au NPB; Ma CHE
    Neurobiol Dis; 2019 Oct; 130():104492. PubMed ID: 31176721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Reduction of Mitochondria Complex I Subunits is Protective against Cisplatin-Induced Neurotoxicity in
    Groen CM; Podratz JL; Pathoulas J; Staff N; Windebank AJ
    J Neurosci; 2022 Feb; 42(5):922-937. PubMed ID: 34893548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neuropathy.
    Fehrenbacher JC
    Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced neuropathy: A comprehensive survey.
    Miltenburg NC; Boogerd W
    Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.
    Argyriou AA; Bruna J; Genazzani AA; Cavaletti G
    Nat Rev Neurol; 2017 Aug; 13(8):492-504. PubMed ID: 28664909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-Induced Peripheral Neuropathic Pain and Rodent Models.
    Hama A; Takamatsu H
    CNS Neurol Disord Drug Targets; 2016; 15(1):7-19. PubMed ID: 26553161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
    Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
    Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations.
    Al-Massri KF; Ahmed LA; El-Abhar HS
    J Tissue Eng Regen Med; 2020 Jan; 14(1):108-122. PubMed ID: 31677248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nmnat mitigates sensory dysfunction in a
    Brazill JM; Cruz B; Zhu Y; Zhai RG
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.